HIV + Hepatitis Policy Institute To CMS: Act Against Texas Insurer Not Covering HIV Meds

By Luke Zarzecki, Amy Lotven / September 29, 2023 at 11:19 AM
The HIV + Hepatitis Institute is urging CMS to take immediate enforcement action against a Texas insurer that the group alleges is “making a mockery” of formulary design requirements by limiting coverage of standard HIV treatments and is discriminating against HIV patients by placing most drugs in high-costs tiers in violation of Affordable Care Act rules. Ahead of 2024 open enrollment season, CMS must ensure all plans are covering HIV treatments as required, the Institute adds. In a complaint filed...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.